Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)
An interview with Dr. Pauline Funchain from Cleveland Clinic, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update...
12 Nov 202112min
Hematologic Toxicities: Management of irAEs Guideline (Part 10)
An interview with Dr. Loretta Nastoupil from MD Anderson Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guidel...
11 Nov 202118min
Nervous System Toxicities: Management of irAEs Guideline (Part 9)
An interview with Dr. Bianca Santomasso from Memorial Sloan Kettering Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy...
10 Nov 202120min
Renal Toxicities: Management of irAEs Guideline (Part 8)
An interview with Dr. Umang Swami from the Huntsman Cancer Institute, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guidelin...
9 Nov 202110min
Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)
An interview with Dr. Maria Suarez-Almazor from MD Anderson Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Gui...
8 Nov 202110min
Endocrine Toxicities: Management of irAEs Guideline (Part 6)
An interview with Dr. Jennifer Mammen from Johns Hopkins University, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline...
5 Nov 202114min
Lung Toxicities: Management of irAEs Guideline (Part 5)
An interview with Dr. Jarushka Naidoo from Johns Hopkins University, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline...
4 Nov 202110min
Gastrointestinal Toxicities: Management of irAEs Guideline (Part 4)
An interview with Dr. Yinghong Wang from MD Anderson Cancer Center, author on "Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline ...
3 Nov 20218min
